text:
|By PR Newswire
Article Rating:
|November 28, 2012 01:20 AM EST
EAST HANOVER, N.J., Nov. 28, 2012 /PRNewswire/ -- Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.
The American Society of Hematology (ASH) annual meeting in Atlanta, held December 8-11, will feature significant data across hematologic diseases including two-year follow-up data from Phase III trials of Jakavi® (ruxolitinib) in patients treated with Jakavi for myelofibrosis and data evaluating molecular response following treatment with Tasigna® (nilotinib) in patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) compared with Gleevec® (imatinib mesylate)* tablets therapy. In addition, updated data on Exjade® (deferasirox) in non-transfusion-dependent thalassemia (NTDT), as well as new data on the removal of cardiac iron in β-thalassemia major, will be presented.
Several studies of novel pipeline compounds will also be presented, including additional Phase I/II findings extending proof-of-concept data for the investigational therapy CTL019 (formerly known as CART-19)† in patients with chronic lymphocytic leukemia (CLL) and relapsed refractory acute lymphoblastic leukemia (ALL)1.
"For more than a decade, Novartis Oncology has discovered critical medicines for cancer patients by following the science," said Herve Hoppenot, President, Novartis Oncology. "The presentations at this year's annual meetings show that our research and development pipeline has never been stronger, and we expect new breakthroughs that could lead to even more innovative therapies for patients."
The CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), held December 4-8, will showcase studies exploring therapy with the mTOR inhibitor Afinitor® (everolimus) and the investigational PI3K inhibitors BYL719 and BKM120 in patients with hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer2.
"Novartis is committed to helping fulfill the large unmet treatment need for patients with advanced breast cancer, and we are continuing to investigate the potential benefits and utility of Afinitor in this population," said Alessandro Riva, Global Head, Oncology Development & Medical Affairs, Novartis Oncology. "The company will also showcase promising results from our pipeline of PI3K/mTOR inhibitors highlighting our commitment to ongoing exploration of compounds that impact key disease pathways."
Highlights at ASH include:
- Jakavi (ruxolitinib) – Long-term safety, efficacy and survival findings from COMFORT-II (COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment), a Phase III study comparing ruxolitinib with best available therapy for the treatment of myelofibrosis (ASH abstract #801; December 10, 6:45 PM EST). Long-term outcome of ruxolitinib treatment in patients with myelofibrosis: durable reductions in spleen volume, improvements in quality of life and overall survival advantage in COMFORT-I (ASH abstract #800; December 10, 6:30 PM EST).
- Tasigna (nilotinib) – Two-year follow-up results from Evaluating Nilotinib Efficacy and Safety in Clinical Trials – Complete Molecular Response (ENESTcmr), evaluating sustained deeper molecular response following a switch to Tasigna in patients with Ph+ CML in chronic phase who still had evidence of residual disease after two or more years of Gleevec therapy (ASH abstract #694; December 10, 5:15 PM EST). Long-term landmark data from Evaluating Nilotinib Efficacy and Safety in Clinical Trials – Newly Diagnosed Patients (ENESTnd), correlating early molecular response and outcome of patients with Ph+ CML in chronic phase (ASH abstract #167; December 9, 5:30 PM EST). Four-year update from ENESTnd evaluating superiority of Tasigna vs. Gleevec in patients with newly diagnosed Ph+ CML in chronic phase (ASH abstract #1676; December 8, 5:30 PM EST).
- Exjade (deferasirox) – Two-year update to THALASSA, the first randomized, placebo-controlled study evaluating reduction of liver iron concentration and serum ferritin in patients with NTDT syndromes after treatment with deferasirox oral iron chelation therapy (ASH abstract #3258; December 10, 6:00 PM EST). First data from CORDELIA, the first head-to-head multicenter, randomized, open-label trial evaluating deferasirox compared with deferoxamine for the removal of cardiac iron in patients with β-thalassemia major and iron overload (ASH abstract #2124; December 9, 6:00 PM EST).
- CTL019 (CART-19) – Outcomes and extended follow-up from a Phase I/II study in patients with advanced, refractory and high-risk CLL and relapsed refractory ALL treated with CART-19 cells (ASH abstract #717; December 10, 5:00 PM EST).
- PKC412 (midostaurin) – First presentation from the pivotal Phase II study of PKC412 in patients with advanced systemic mastocytosis and mast cell leukemia (ASH abstract #799; December 10, 6:15 PM EST).
- LBH589 (panobinostat) – Updated results from PANORAMA-2 (PANobinostat ORAl in Multiple myelomA) Phase II study of LBH589 in combination with bortezomib (BTZ) and dexamethasone in patients with relapsed and BTZ-refractory multiple myeloma (ASH abstract #1852; December 8, 5:30 PM EST).
Highlights at SABCS include:
- Afinitor (everolimus) – New data from a Phase II clinical trial evaluating Afinitor (everolimus) in combination with fulvestrant in postmenopausal women with HR+ advanced breast cancer who progressed on a previous endocrine therapy (SABCS abstract #P2-14-05; December 6, 7:00 AM CST) and an additional Phase II study evaluating the potential efficacy of Afinitor in combination with letrozole (SABCS abstract #P5-20-06; December 7, 5:00 PM CST). Final progression-free survival analysis of BOLERO-2 Phase III trial of Afinitor plus exemestane for postmenopausal women with HR+/HER2- advanced breast cancer after failure of letrozole or anastrazole (SABCS abstract #P6-04-02; December 8, 7:00 AM CST).
- BYL719 – Preliminary results from a Phase I study of BYL719 in patients with PIK3CA mutant ER+ metastatic breast cancer (SABCS abstract #P6-10-07; December 8, 7:00 AM CST).
- BKM120 – Abstract highlighting trial in progress BELLE-3 Phase III randomized study of PI3K inhibitor BKM120 in combination with fulvestrant in postmenopausal women with HR+/HER2- advanced breast cancer whose disease has progressed after treatment with an aromatase inhibitor and on or after an mTOR inhibitor (SABCS abstract #OT2-3-08; December 6, 5:00 PM CST).
- LBH589 (panobinostat) – Pre-clinical data explores the potential utility of HDAC inhibition in triple-negative breast cancer alone and in combination with other agents (SABCS abstract #S3-7; December 6, 9:30 AM CST).
About Jakavi
Jakavi® (INC424, ruxolitinib) is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases3 and was approved by the European Commission in August 2012 for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis. Jakavi is available in more than 30 countries including the European Union member states and Canada, with additional global regulatory filings underway.
Novartis licensed INC424 (ruxolitinib) from Incyte Corporation for development and commercialization outside the US. Both the European Commission and the US Food and Drug Administration (FDA) granted INC424 (ruxolitinib) orphan drug status for myelofibrosis. Jakavi is marketed in the United States by Incyte Corporation under the name Jakafi® for the treatment of patients with intermediate or high-risk myelofibrosis.
Jakavi is a registered trademark of Novartis AG in countries outside the United States. Jakafi is a registered trademark of Incyte Corporation.
Jakavi® Important Safety Information
Jakavi® can cause serious side effects, including a decrease in blood cell count and infections. Complete blood count monitoring is recommended. Dose reduction or interruption may be required in patients with severe hepatic or renal impairment or in patients developing hematologic adverse reactions such as thrombocytopenia, anemia and neutropenia. Dose reductions are also recommended when Jakavi is co-administered with strong CYP3A4 inhibitors or fluconazole. Use of Jakavi during pregnancy is not recommended and women should avoid becoming pregnant during Jakavi therapy. Women taking Jakavi should not breast feed.
The most common adverse drug reactions, occurring at any level of severity, (incidence >10%) are urinary tract infections, anemia, thrombocytopenia, neutropenia, hypercholesterolaemia, dizziness, headache, alanine aminotransaminase increased, asparte aminotransferase increased, bruising, bleeding and increased blood pressure. Other common adverse drug reactions (incidence 1 to 10%) are herpes zoster, weight gain, flatulence and tuberculosis (1%).
About Tasigna
TASIGNA® (nilotinib) is approved for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The effectiveness of TASIGNA for this indication is based on major molecular response and cytogenetic response rates at 12 months. The study is ongoing and further data will be required to determine long-term outcome.
TASIGNA is also approved in more than 90 countries for the treatment of chronic phase and accelerated phase Ph+ CML in adult patients resistant or intolerant to at least one prior therapy, including Gleevec. The effectiveness of TASIGNA for this indication is based on hematologic and cytogenetic response rates.
BOXED WARNING and Important Safety Information for TASIGNA (nilotinib):
TASIGNA prolongs the QT interval. Prior to TASIGNA administration and periodically, monitor for hypokalemia or hypomagnesemia and correct deficiencies. Obtain ECGs to monitor the QTc at baseline, seven days after initiation, and periodically thereafter, and follow any dose adjustments.
Sudden deaths have been reported in patients receiving nilotinib. Do not administer TASIGNA to patients with hypokalemia, hypomagnesemia, or long QT syndrome.
Avoid use of concomitant drugs known to prolong the QT interval and strong CYP3A4 inhibitors.
Patients should avoid food 2 hours before and 1 hour after taking dose.
Treatment with TASIGNA can cause Grade 3/4 thrombocytopenia, neutropenia, and anemia. Complete blood counts should be performed every 2 weeks for the first 2 months and then monthly thereafter.
Caution is recommended in patients with a history of pancreatitis.
The use of TASIGNA may result in elevations in bilirubin, AST/ALT, and alkaline phosphatase.
TASIGNA can cause hypophosphatemia, hypokalemia, hyperkalemia, hypocalcemia, and hyponatremia (see Boxed WARNING).
The concomitant use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (including, but not limited to, amiodarone, disopyramide, procainamide, quinidine, and sotalol) and other drugs that may prolong the QT interval (including, but not limited to, chloroquine, clarithromycin, haloperidol, methadone, moxifloxacin, and pimozide) should be avoided. Grapefruit products should also be avoided.
The concomitant use of strong CYP3A4 inducers should be avoided (including, but not limited to, dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, and St. John's wort).
TASIGNA must not be taken with food.
TASIGNA exposure is increased in patients with impaired hepatic function.
Cases of tumor lysis syndrome have been reported in TASIGNA treated patients with resistant or intolerant CML. Due to potential for tumor lysis syndrome, maintain adequate hydration and correct uric acid levels prior to initiating therapy with TASIGNA.
The exposure of TASIGNA is reduced in patients with total gastrectomy.
Since the capsules contain lactose, TASIGNA is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency with a severe degree of intolerance to lactose-containing products, or of glucose-galactose malabsorption.
Women of childbearing potential should avoid becoming pregnant while taking TASIGNA and should be advised of the potential hazard to the fetus if they do. The safety and effectiveness of TASIGNA in pediatric patients have not been established.
In newly diagnosed Ph+ CML-chronic phase, the most commonly reported nonhematologic adverse drug reactions (>10%) were rash, pruritus, headache, nausea, fatigue, and myalgia.
In resistant or intolerant Ph+ CML-chronic phase, the most commonly reported nonhematologic adverse drug reactions (greater than or equal to 10%) were rash, pruritus, nausea, fatigue, headache, constipation, diarrhea, vomiting, and myalgia.
In resistant or intolerant Ph+ CML-accelerated phase, the most commonly reported nonhematologic adverse drug reactions (greater than or equal to 10%) were rash, pruritus, and fatigue.
TASIGNA may need to be temporarily withheld and/or dose reduced for QT prolongation, hematologic toxicities that are not related to underlying leukemia, clinically significant moderate or severe nonhematologic toxicities, laboratory abnormalities, or concomitant use of strong CYP3A4 inhibitors.
Please see full Prescribing Information including Boxed Warning.
About Gleevec
Gleevec® (imatinib mesylate) tablets are indicated for newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP). Gleevec is also indicated for the treatment of patients with Ph+ CML in blast crisis (BC), accelerated phase (AP), or in CP after failure of interferon-alpha therapy.
GLEEVEC® Important Safety Information
GLEEVEC can cause fetal harm when administered to a pregnant woman. Women should not become pregnant, and should be advised of the potential risk to the unborn child.
GLEEVEC is often associated with edema (swelling) and serious fluid retention. Studies have shown that edema (swelling) tended to occur more often among patients who are 65 and older or those taking higher doses of GLEEVEC.
Cytopenias (reduction or lack of certain cell elements in blood circulation), such as anemia, have occurred. If the cytopenia is severe, your doctor may reduce your dose or temporarily stop your treatment with GLEEVEC.
Severe congestive heart failure and left ventricle dysfunction have been reported, particularly in patients with other health issues and risk factors. Patients with heart disease or risk factors or history of renal failure will be monitored and treated for the condition.
Severe liver problems (hepatotoxicity) may occur. Cases of fatal liver failure and severe liver injury requiring liver transplants have been reported with both short-term and long-term use of GLEEVEC.
Bleeding may occur. Severe gastrointestinal (GI) bleeding has been reported in patients with KIT+ GIST. GI tumor sites may be the cause of this bleeding; therefore, GI symptoms should be monitored at the start of treatment.
In patients with hypereosinophilic syndrome (a condition with increased eosinophils, which are a type of white blood cell) and heart involvement, cases of heart disease (cardiogenic shock/left ventricular dysfunction) have been associated with the initiation of GLEEVEC therapy.
Skin reactions, such as fluid-filled blisters, have been reported with the use of GLEEVEC.
Clinical cases of hypothyroidism (reduction in thyroid hormones) have been reported in patients taking levothyroxine replacement with GLEEVEC.
Long-term use may result in potential liver, kidney, and/or heart toxicities; immune system suppression may also result from long-term use.
GI perforation (small holes or tears in the walls of the stomach or intestine), in some cases fatal, has been reported.
Growth retardation has been reported in children taking GLEEVEC. The long-term effects of extended treatment with GLEEVEC on growth in children are unknown.
Cases of tumor lysis syndrome (TLS), which refers to a metabolic and electrolyte disturbance caused by the breakdown of tumor cells, have been reported and can be life-threatening in some cases. Correction of clinically significant dehydration and treatment of high uric acid levels are recommended prior to initiation of GLEEVEC.
Reports of motor vehicle accidents have been received in patients receiving GLEEVEC. Caution patients about driving a car or operating machinery.
Almost all patients treated with GLEEVEC experience side effects at some time. Some common side effects you may experience are fluid retention, muscle cramps or pain and bone pain, abdominal pain, loss of appetite, vomiting, diarrhea, decreased hemoglobin, abnormal bleeding, nausea, fatigue and rash.
GLEEVEC is sometimes associated with stomach or intestinal irritation. GLEEVEC should be taken with food and a large glass of water to minimize this problem. There have been rare reports, including deaths, of stomach or intestinal perforation (a small hole or tear).
If you are experiencing any of the mentioned side effects, please be sure to speak with your doctor immediately.
Do not take any other medications without talking to your doctor or pharmacist first, including Tylenol® (acetaminophen); herbal products (St. John's wort, Hypericum perforatum); Coumadin® (warfarin sodium); rifampin; erythromycin; metoprolol; ketoconazole; and Dilantin® (phenytoin). Taking these with GLEEVEC may affect how they work, or affect how GLEEVEC works.
You should also tell your doctor if you are taking or plan to take iron supplements. Patients should also avoid grapefruit juice and other foods that may affect how GLEEVEC works.
Please see full Prescribing Information.
About Exjade
Exjade® is an oral iron chelation therapy indicated for the treatment of chronic iron overload due to blood transfusions in adult and pediatric patients (aged 2 years and over). It is approved in more than 100 countries including the US, Switzerland, Japan and the countries comprising the EU. The approved indication may vary depending upon the individual country.
Exjade® Important Safety Information
Exjade is contraindicated in patients with creatinine clearance <40 mL/min or serum creatinine >2 times the age-appropriate upper limit of normal; poor performance status and high-risk myelodysplastic syndromes or advanced malignancies: platelet counts <50 x 109/L; known hypersensitivity to deferasirox or any component of Exjade.
There have been postmarketing reports of acute renal failure, hepatic failure and cytopenias. Renal failure requiring temporary or permanent dialysis, renal tubulopathy and interstitial nephritis have been reported. Upper gastrointestinal ulceration and hemorrhage, sometimes fatal, have been reported. Caution should be used in elderly patients due to a higher frequency of adverse reactions. Exjade is not recommended in patients with a short life expectancy (e.g., high-risk myelodysplastic syndromes), especially when co-morbidities could increase the risk of adverse events.
Skin rashes, serious hypersensitivity reactions, decreased hearing and lens opacities have been reported. The most common adverse reactions are nausea, vomiting, diarrhea, abdominal pain, rash, non‐progressive increases in serum creatinine, increased transaminases, abdominal distension, constipation, dyspepsia, proteinuria and headache.
Please visit www.exjade.com. The full prescribing information including the Boxed Warning for Exjade is available at http://www.pharma.us.novartis.com/product/pi/pdf/exjade.pdf.
About Afinitor (everolimus)
Afinitor® (everolimus) is approved in the United States for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
For more information visit www.AFINITOR.com or call 1-888-4-AFINITOR. US patients who may be eligible for financial assistance can learn about the Novartis Patient Assistance Now Oncology (PANO) reimbursement support program by contacting 1-800-282-7630 or visiting the Afinitor website.
In the United States, Afinitor tablets is approved for the treatment of adult patients with advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib and for the treatment of progressive neuroendocrine tumors of pancreatic origin in adult patients with unresectable, locally advanced or metastatic disease. The US Food and Drug Administration (FDA) determined that the safety and effectiveness of Afinitor in the treatment of patients with carcinoid tumors have not been established.
Afinitor is approved for the treatment of adult patients with renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery. The effectiveness of Afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes. In addition, Afinitor and Afinitor Disperz™ are approved in the United States in pediatric and adult patients with TSC for the treatment of subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected. Effectiveness is based on demonstration of durable objective response, as evidenced by reduction in SEGA tumor volume. Improvement in disease-related symptoms and overall survival in patients with SEGA and TSC have not been demonstrated.
In the United States, Afinitor is available from Novartis in different dosage strengths and for different uses in non-oncology patient populations under the trade name Zortress®. Everolimus is exclusively licensed to Abbott and sublicensed to Boston Scientific for use in drug-eluting stents.
Not all indications are available in every country. Access to Afinitor outside of the approved indications has been carefully controlled and monitored in clinical trials designed to better understand the potential benefits and risks of the compound. As an investigational compound, the safety and efficacy profile of Afinitor has not yet been established outside the approved indications. Because of the uncertainty of clinical trials, there is no guarantee that Afinitor will become commercially available for additional indications anywhere else in the world.
Afinitor® Important Safety Information
Patients should not take Afinitor or Afinitor Disperz if they are allergic to Afinitor or Afinitor Disperz or to any of its ingredients. Patients should tell their healthcare provider before taking Afinitor or Afinitor Disperz if they are allergic to sirolimus (Rapamune®) or temsirolimus (Torisel®).
Afinitor or Afinitor Disperz can cause serious side effects, including lung or breathing problems, infections, and kidney failure, which can even lead to death. If patients experience these side effects, they may need to stop taking Afinitor or Afinitor Disperz for a while or use a lower dose. Patients should follow their healthcare provider's instructions.
In some patients, lung or breathing problems may be severe and can even lead to death. Patients should tell their healthcare provider right away if they have any of these symptoms: new or worsening cough, shortness of breath, chest pain, difficulty breathing, or wheezing.
Afinitor or Afinitor Disperz may make patients more likely to develop an infection, such as pneumonia, or a bacterial, fungal, or viral infection. Viral infections may include reactivation of hepatitis B in people who have had hepatitis B in the past. In some people these infections may be severe and can even lead to death. Patients may need to be treated as soon as possible. Patients should tell their healthcare provider right away if they have a temperature of 100.5˚F or above, chills, or do not feel well. Symptoms of hepatitis B or infection may include the following: fever, chills, skin rash, joint pain and inflammation, tiredness, loss of appetite, nausea, pale stools or dark urine, yellowing of the skin, or pain in the upper right side of the stomach.
Afinitor or Afinitor Disperz may cause kidney failure. In some people this may be severe and can even lead to death. Patients should have tests to check their kidney function before and during their treatment with Afinitor or Afinitor Disperz.
Common side effects include mouth ulcers. Afinitor or Afinitor Disperz can cause mouth ulcers and sores. Other common side effects include infections, feeling weak or tired, nausea and vomiting, skin problems, headache, weight loss, loss of appetite, cough, diarrhea, fever, swelling of the hands, arms, legs, feet, face, or other parts of the body, joint pain, abnormal taste, stomach-area (abdomen) pain, nose bleeds, seizure, increased blood cholesterol and sugar levels, decreased blood phosphate levels, low red and white blood cells, and the absence of menstrual periods (menstruation).
Please see full Prescribing Information for AFINITOR and AFINITOR DISPERZ available at AFINITOR.com.
About CTL019, PKC412, LBH589 and BKM120
Because these are investigational compounds, the safety and efficacy profile of CTL019, PKC412, LBH589 and BKM120 have not yet been established. Access to these investigational compounds is available only through carefully controlled and monitored clinical trials. These trials are designed to better understand the potential benefits and risks of the compound. Because of uncertainty of clinical trials, there is no guarantee that CTL019, PKC412, LBH589 and BKM120 will ever be commercially available anywhere in the world.
The foregoing release contains forward-looking statements that can be identified by terminology such as "pipeline," "ongoing," "commitment," "will," "expects," "could," "committed," "potential," "exploration," "explores," or similar expressions, or by express or implied discussions regarding potential marketing submissions or approvals for investigational compounds, or potential new indications or labeling for existing products, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any of the investigational compounds referred to in this release will be submitted or approved for sale in any market, or at any particular time. Nor can there be any guarantee that any of the approved products referred to in this release will be submitted or approved for any additional indications or labeling in any market, or at any particular time. Neither can there be any guarantee that any of the investigational compounds or products referred to in this release will achieve any particular levels of revenue in the future. In particular, management's expectations regarding such products could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; competition in general; government, industry and general public pricing pressures; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; unexpected manufacturing issues; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative prescription drugs used to treat a number of diseases and conditions, including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease and respiratory. The company's mission is to improve people's lives by pioneering novel healthcare solutions.
Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2011, the Group's continuing operations achieved net sales of USD 58.6 billion, while approximately USD 9.6 billion (USD 9.2 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 127,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.
* Known as Glivec® (imatinib) outside the US, Canada and Israel.
† CTL019 is developed in collaboration with the University of Pennsylvania.
1. American Society of Hematology. ASH Annual 2012 Meeting Program. Available at https://ash.confex.com/ash/2012/webprogram/start.html. Accessed November 2012.
2. San Antonio Breast Cancer Symposium. SABCS Annual 2012 Meeting Program. Available at http://www.sabcs.org/ProgramSchedule/index.asp. Accessed November 2012.
3. JAKAVI [Summary of Product Characteristics]. Basel, Switzerland: Novartis Pharma AG; 2012.
Novartis Media Relations
Julie Masow
Novartis Corporation
+1 212 830 2465 (direct)
+1 862 579 8456 (mobile)
e-mail: [email protected]
Gloria Vanderham
Novartis Oncology
+1 862 778 4268 (direct)
+1 862 926 8420 (mobile)
For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis.
For questions about the site or required registration, please contact: [email protected].
SOURCE Novartis
"We have a tagline - "Power in the API Economy." What that means is everything that is built in applications and connected applications is done through APIs," explained Roberto Medrano, Executive Vice President at Akana, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Jul. 1, 2015 05:00 PM EDT Reads: 714
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists addressed this very serious issue of profound change in the industry.
Jul. 1, 2015 03:30 PM EDT Reads: 1,015
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In his session at @ThingsExpo, James Kirkland, Red Hat's Chief Architect for the Internet of Things and Intelligent Systems, described how to revolutionize your archit...
Jul. 1, 2015 02:21 PM EDT Reads: 460
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society-changing applications of the future? The technology won't be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his session at @ThingsExpo, Jason Mondanaro, Director, Product Management at Metanga, discussed how you can plan to cooperate, partner, and form lasting all-star teams to change the world and it starts with business models and monetization strategies.
Jul. 1, 2015 11:30 AM EDT Reads: 2,234
To many people, IoT is a buzzword whose value is not understood. Many people think IoT is all about wearables and home automation. In his session at @ThingsExpo, Mike Kavis, Vice President & Principal Cloud Architect at Cloud Technology Partners, discussed some incredible game-changing use cases and how they are transforming industries like agriculture, manufacturing, health care, and smart cities. He will discuss cool technologies like smart dust, robotics, smart labels, and much more. Prepare to be blown away with a glimpse of the future.
Jul. 1, 2015 11:30 AM EDT Reads: 751
Internet of Things is moving from being a hype to a reality. Experts estimate that internet connected cars will grow to 152 million, while over 100 million internet connected wireless light bulbs and lamps will be operational by 2020. These and many other intriguing statistics highlight the importance of Internet powered devices and how market penetration is going to multiply many times over in the next few years.
Jul. 1, 2015 10:30 AM EDT Reads: 2,121
Internet of Things (IoT) will be a hybrid ecosystem of diverse devices and sensors collaborating with operational and enterprise systems to create the next big application. In their session at @ThingsExpo, Bramh Gupta, founder and CEO of robomq.io, and Fred Yatzeck, principal architect leading product development at robomq.io, discussed how choosing the right middleware and integration strategy from the get-go will enable IoT solution developers to adapt and grow with the industry, while at the same time reduce Time to Market (TTM) by using plug and play capabilities offered by a robust IoT ...
Jul. 1, 2015 09:45 AM EDT Reads: 1,930
Today air travel is a minefield of delays, hassles and customer disappointment. Airlines struggle to revitalize the experience. GE and M2Mi will demonstrate practical examples of how IoT solutions are helping airlines bring back personalization, reduce trip time and improve reliability. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Dr. Sarah Cooper, M2Mi's VP Business Development and Engineering, will explore the IoT cloud-based platform technologies driving this change including privacy controls, data transparency and integration of real time context wi...
Jul. 1, 2015 08:00 AM EDT Reads: 897
SYS-CON Events announced today that BMC will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. BMC delivers software solutions that help IT transform digital enterprises for the ultimate competitive business advantage. BMC has worked with thousands of leading companies to create and deliver powerful IT management services. From mainframe to cloud to mobile, BMC pairs high-speed digital innovation with robust IT industrialization – allowing customers to provide amazing user experiences with optimized IT per...
Jun. 29, 2015 12:15 PM EDT Reads: 2,686
There will be 150 billion connected devices by 2020. New digital businesses have already disrupted value chains across every industry. APIs are at the center of the digital business. You need to understand what assets you have that can be exposed digitally, what their digital value chain is, and how to create an effective business model around that value chain to compete in this economy. No enterprise can be complacent and not engage in the digital economy. Learn how to be the disruptor and not the disruptee.
Jun. 29, 2015 11:00 AM EDT Reads: 2,187
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will addresses this very serious issue of profound change in the industry.
Jun. 29, 2015 09:45 AM EDT Reads: 2,534
Business as usual for IT is evolving into a "Make or Buy" decision on a service-by-service conversation with input from the LOBs. How does your organization move forward with cloud? In his general session at 16th Cloud Expo, Paul Maravei, Regional Sales Manager, Hybrid Cloud and Managed Services at Cisco, discusses how Cisco and its partners offer a market-leading portfolio and ecosystem of cloud infrastructure and application services that allow you to uniquely and securely combine cloud business applications and services across multiple cloud delivery models.
Jun. 28, 2015 11:00 AM EDT Reads: 2,234
In his General Session at 16th Cloud Expo, David Shacochis, host of The Hybrid IT Files podcast and Vice President at CenturyLink, investigated three key trends of the "gigabit economy" though the story of a Fortune 500 communications company in transformation. Narrating how multi-modal hybrid IT, service automation, and agile delivery all intersect, he will cover the role of storytelling and empathy in achieving strategic alignment between the enterprise and its information technology.
Jun. 27, 2015 10:00 AM EDT Reads: 2,257
Buzzword alert: Microservices and IoT at a DevOps conference? What could possibly go wrong? In this Power Panel at DevOps Summit, moderated by Jason Bloomberg, the leading expert on architecting agility for the enterprise and president of Intellyx, panelists peeled away the buzz and discuss the important architectural principles behind implementing IoT solutions for the enterprise. As remote IoT devices and sensors become increasingly intelligent, they become part of our distributed cloud environment, and we must architect and code accordingly. At the very least, you'll have no problem fillin...
Jun. 26, 2015 12:00 PM EDT Reads: 2,243
Growth hacking is common for startups to make unheard-of progress in building their business. Career Hacks can help Geek Girls and those who support them (yes, that's you too, Dad!) to excel in this typically male-dominated world. Get ready to learn the facts: Is there a bias against women in the tech / developer communities? Why are women 50% of the workforce, but hold only 24% of the STEM or IT positions? Some beginnings of what to do about it! In her Opening Keynote at 16th Cloud Expo, Sandy Carter, IBM General Manager Cloud Ecosystem and Developers, and a Social Business Evangelist, d...
Jun. 26, 2015 10:00 AM EDT Reads: 2,120
Converging digital disruptions is creating a major sea change - Cisco calls this the Internet of Everything (IoE). IoE is the network connection of People, Process, Data and Things, fueled by Cloud, Mobile, Social, Analytics and Security, and it represents a $19Trillion value-at-stake over the next 10 years. In her keynote at @ThingsExpo, Manjula Talreja, VP of Cisco Consulting Services, discussed IoE and the enormous opportunities it provides to public and private firms alike. She will share what businesses must do to thrive in the IoE economy, citing examples from several industry sectors.
Jun. 25, 2015 02:00 PM EDT Reads: 2,035
In his keynote at 16th Cloud Expo, Rodney Rogers, CEO of Virtustream, discussed the evolution of the company from inception to its recent acquisition by EMC – including personal insights, lessons learned (and some WTF moments) along the way. Learn how Virtustream's unique approach of combining the economics and elasticity of the consumer cloud model with proper performance, application automation and security into a platform became a breakout success with enterprise customers and a natural fit for the EMC Federation.
Jun. 25, 2015 01:30 PM EDT Reads: 2,191
SYS-CON Events announced today that the "Second Containers & Microservices Conference" will take place November 3-5, 2015, at the Santa Clara Convention Center, Santa Clara, CA, and the "Third Containers & Microservices Conference" will take place June 7-9, 2016, at Javits Center in New York City. Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities.
Jun. 22, 2015 02:15 PM EDT Reads: 2,831
SYS-CON Events announced today that the "First Containers & Microservices Conference" will take place June 9-11, 2015, at the Javits Center in New York City. The "Second Containers & Microservices Conference" will take place November 3-5, 2015, at Santa Clara Convention Center, Santa Clara, CA. Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities.
Jun. 20, 2015 12:00 PM EDT Reads: 3,900
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo in Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal an...
Jun. 15, 2015 08:45 PM EDT Reads: 4,146


text: This is our second year staying at Golden Sands and we couldn't be happier with our experiences. In spite of the holiday price tag, we eagerly returned, knowing our time and money would be well spent. Rooms are standard, mid-range, beach motel decor, so if you're looking for Ikea or Crate & Barrel decor, you won't get it here. What... More

subset: commoncrawl


text:
Auction price: Register or sign-in to see quarterly averages
or visit the Wine Market Journal
Drink between: 2009 - 2023 (Add My Dates)
841 Tasting Notes
207 Tasting Notes
153 Tasting Notes
Friday Night Double Blind Tasting $40+ (Bin 75): Dark red core showing some clarity, dull garnet rim; funk right off the bat, sour cherry, raspberry, bitter, fig paste, slight vanilla, nori; old school on the palate, very tart and sour hard red fruit, cranberry, raspberry, less fig, strong bitter aspirin finish which could be austere for many, hot stone minerality, fresh, great mid-palate, Burgundian; a CdP for CdP purists, love the Grenache, very pure, great transparency; could go 10+ more years and probably improve, 92+.
Needed a bit of time to open up. Still fairly primary and simple with shadings of crushed black pepper and a little dark honey to go along with mostly red and a little darker fruit. Silky and elegant. Ann loved it. I'll wait five plus years before opening another to see if it gains some complexity.
Still tannic and taking >1 hour to open, the peak was complex and exciting but brief, giving way to dryness on the other side. With further bottle ageing the tannins are likely to dissipate but will there be any fruit left? This wine is in a tough spot.
Decent wine served in a bad spot, it followed an 88 Mouton so it seemed sweet, simple and flabby. It was actually a nice CdP with nice raspberry and earth notes.
An absolute beautiful wine. I personally didn't decant this long enough, it needed at least 3 hours before really showing itself. Tannins have been shed, leaving floral, strawberry, and scents of tar. This wine is at its prime.


text:
a book by Joyce Carol Oates
An Otto Penzler Book The need for love—obsessive, self-destructive, unpredictable—takes us to forbidden places, as in the chilling world of Give Me Your Heart, a new collection of stories by the inimitable Joyce Carol Oates. … see full wiki
What did you think of this review?
a book by Joyce Carol Oates
A book by Gabriel Garcia Marquez
A novel by the American author F. Scott Fitzgerald


text:
Smite continues to stretch the definition of "god" with Ravana, the Demon King of Lanka. Available in today's big Combo Breaker update for the PC MOBA, Ravana achieved something akin to godhood by cutting off his own head 10 times. Show off. »
Okay, Maybe The Gameplay Isn't My Favorite Feature Of Smite
The latest patch for action MOBA Smite dropped today, adding achievements, a brand new god, a revamped store interface and all sorts of item and god balance tweaks. Great! I'll just watch this menu animation for the two dozenth time then. »
Driveclub's Dynamic Weather Update Completely Changes The Game
Two days ago I was bored with Driveclub. Today each race is exhilarating, often terrifyingly so, and all that's changed is the weather. »
Mario Kart 8's Online Multiplayer Is Coming Back To Life
Last week was Thanksgiving, a holiday often celebrated with family. For many gamers, this means a lot of time spent playing Nintendo games. I, for one, spent most nights playing Mario Kart 8 with my brother. Doing so led to a surprising discovery about its online multiplayer: it's gotten a lot better as of late. »
Free Update Transforms Goat Simulator Into Goat MMO Simulator
In honor of the people who purchased a bajillion copies of a game that simulates goats poorly, this Thursday developer Coffee Stain Studios is releasing Goat Simulator update 1.2, AKA Goat MMO Simulator. Really. »
Shadow of Mordor is adding some new epic runes and an alternate skin that lets you dress up as Sauron's Black Hand, publisher Warner Bros. announced today. Keep in mind you only look like the villain—you're not actually gaining evil powers. The free update is out now for the Xbox One, with PS4 and PC versions to come. »
Sony just published a list of additions it's bringing to the PS4 with the upcoming 2.0 system update. A few neat things stand out, such as the ability to add a PS Plus game "to a PS4 owner's library without downloading it." Or shout, "Find face!" at your console and have it respond. Read the full thing here. »
Your Shadow Of Mordor Screenshots Just Got Snazzier (UPDATE)
What's better than ogling buckets and buckets of orc gore in Shadow of Mordor? Spiffing up those same heaping piles of gratuity with Instagram-esque filters, you say? Well, if you actually did say that, then boy do I have the thing for you. »
Oh My Gosh, Nintendo Gave Link A Motorcycle
If Zelda making its first appearance in Mario Kart wasn't exciting enough, Nintendo sweetened the deal today. When Link (if that is his real name) arrives in Mario Kart 8 next month, the company said he'll be bringing a new kart-friendly version of his trusty steed with him. »
Minecraft's Latest Update Is Huge, Took Ten Months to Make
Chickens, cows and pigs have been the only meat-giving animals in Minecraft for a long time now, and, in one of the most welcome changes included in the game's latest big patch, they are now joined by sheep. »
Now that's a Yoshi of a different color! As part of its big Mario Kart 8 update announcement yesterday, Nintendo revealed that two of the game's most popular characters—Shy Guy and Yoshi—are now available in eight different shades. They all look pretty great: »
Diablo III: Reaper of Souls Gets Its First Major Update
2.1.0 brings with it a competitive game mode based on Diablo II's online ladders, called Seasons, and a new type of endgame dungeon: Greater Rifts. »
Now Final Fantasy XIV Has Private Quarters And Chocobo Raising
Role-players and giant chicken aficionados rejoice! Today's the day Final Fantasy XIV's "defenders of Eorzea" patch arrives, giving players private rooms, the ability to raise chocobos, and plenty of questing and hunting to keep others occupied while you're in your private rooms. »
Final Fantasy VIII PC Update Brings Fresh Cheats, High Speed Mode
Want to experience Final Fantasy VIII without struggling against enemies or waiting on super-long cutscenes and dialog sessions? An update for the PC version of Square Enix's 15-year-old RPG makes it so, so easy. »
Titanfall's newest patch lets PC players jack up the framerate to an "extreme" 144 fps. It also adds a lot of custom options for the new Private Match game type and a new round of game balance changes. »
Minecraft's New Terrain Generator Looks Amazing
Mojang has been slowly teasing out details about the next big update for Minecraft for a while now. This Tuesday, the team decided to drop a bombshell on fans of the legendary PC game in the form of a quiet little YouTube video announcing how players will soon be able "to create their own wild and crazy terrain!" »
Titanfall's Next New Modes Will Be Free
During their PAX East panel today, Respawn announced that they're working on new modes for Titanfall. These updates, in addition to other micro updates that they've already been working on, will be completely free to owners of the game. »
Titanfall Is Getting Private Matches
It's a general rule that most constantly-connnected competitive shooters will evolve and change a whole lot in their lifetimes. Titanfall's the newest king of the hill in FPSland and the hit game is no exception. There's a new patch inbound for the hit game and it's reconfiguring a lot of stuff. Among other things,… »
Now That's An Impressive Boss Monster, Guild Wars 2
The living story that ran through 2013 in Guild Wars 2 escalates in 2014, as the arch-villain Scarlet Briar unleashes a massive mechanical monstrosity on the unsuspecting denizens of Tyria. Meet the Twisted Marionette. »
Heads up: the Miiverse update for the 3DS is now live. With the update comes the ability to interact with Nintendo's Miiverse on any 3DS (and 2DS, and 3DSXL) system, along with Nintendo Network ID support for the eShop. More info here and full patch notes here. »


text:
Medieval and Ancient History NewsMedievalists.nethttp://firstname.lastname@example.com/IDwLhttps://feedburner.google.com
URL: http://feedproxy.google.com/~r/blogspot/IDwL/~3/eAPIx9KkU_Q/irish-brain-surgeons-vikings-who.html
Updated: 41 min 48 sec ago
What's being found, what's being restored - Medieval News Roundup
Recent news for medievalists, including the restoration of a 15th-century manuscript, and the discovery of a Norman castle. And check out the great video from the people behind Just for Laughs Gags:
[View the story "What's being found, what's being restored - Medieval News Roundup" on Storify]
Magna Carta Roundup
The 800th anniversary of the creation of Magna Carta was a major event, and here is a roundup of how newspapers and other media covered it.
[View the story "Magna Carta Roundup" on Storify]
Her Majesty The Queen unveils a plaque commemorating 800 years of Magna Carta - Photo courtesy Surrey County Council
Medieval News Roundup: From London to New York
Even Ethan Hawke made the medieval news this week!
[View the story "Medieval News Roundup: From London to New York" on Storify]
From Kempe to the Congress - 5 medieval articles in the news
We bring you five articles from the last couple of days about the Middle Ages. Do you like this format?
New evidence supports Margery Kempe's accountSome scholars have suspected that Margery Kempe's account of her religious life and pilgrimages were made up, but a letter from her son has just been uncovered...
Archaeological finds at Littlemore Priory
Update on the Mass Grave discovered in ParisThe total number of human remains uncovered in the basement of a Paris supermarket reaches 316 according to an update from the New York Times
Local media on the 50th International Congress on Medieval StudiesTime again for the congress! Will you be there?Yes, Ill be there!No, I'm not going
Photo by Denis Gliksman/Inrap
The Middle Ages are Not 'Medieval' and more medieval news
This week's roundup of news for medievalists...
[View the story "The Middle Ages are Not 'Medieval' and more medieval news" on Storify]
Discoveries, Donations and Digs: Medieval News Roundup
A couple dozen items to share with you as we get caught up with the medieval news from the last few weeks...
[View the story "Discoveries, Donations and Digs: Medieval News Roundup" on Storify]
Finally, we wanted to show you this beautiful video of a 16th century Irish castle...
Reacting to Medieval Reactions
In mid-March a new Twitter account came into being: @MedievalReacts
[View the story "Reacting to Medieval Reactions" on Storify]
How Richard III is being covered around the world, and more medieval news
We begin with a selection of news stories about the reinterment of Richard III, some serious and some odd, from media around the world.
[View the story "How Richard III is being covered around the world, and more medieval news" on Storify]
User login
Partner Sites


text:
Originally written on Fox Sports West | Last updated 4/5/12
Clayton Kershaw must have been spending too much time around Andre Ethier. Ethier missed Saturdays Freeway Series game against the Angels with a stomach bug, and it apparently made its way to Clayton Kershaw. Kershaw started the season opener for the Dodgers on Thursday, despite battling the flu. After three innings, however, the flu won and Kershaw left the game against the Padres. Kershaw did not give up a run in his three innings, walking one and striking out one. He also had the Dodgers first single, so at least he left with a perfect ERA and batting average. The decision to start Kershaw could come back to haunt the Dodgers, however, as they will now have to use much of their bullpen in the first game of the year. The Dodgers have three more games scheduled against the Padres over the weekend. Josh Lindblom, making his first appearance on an opening-day roster, took over for Kershaw to start the fourth. --Steve Dilbeck
Comments are closed.
What do you think?To leave a comment, you can:
MLB News
Delivered to your inbox
You'll also receive Yardbarker's daily Top 10, featuring the best sports stories from around the web. Customize your newsletter to get articles on your favorite sports and teams. And the best part? It's free!
Follow us on Twitter
|Best of Yardbarker
|NFL News
|MLB News
Today's Best Stuff
For Bloggers
Join the Yardbarker Network for more promotion, traffic, and money.
Company Info
What is Yardbarker?
Yardbarker is the largest network of sports blogs and pro athlete blogs on the web. This site is the hub of the Yardbarker Network, where our editors and algorithms curate the best sports content from our network and beyond.
|© 2015 Yardbarker, Inc. All rights reserved. Use of this website (including any and all parts and components) constitutes your acceptance of these Terms of Use and Privacy Policy. (What's New?)


text:
Buy Item $16.99 Retail:
Save 15% ($3.01)
Add To Cart
Add To Wishlist
Photo frame for a favorite 6" x 4" picture; 7" high; easel backed and ready for desk display at work or home. Gift idea for men of all ages include pastors and ministry leaders.
Jermiah 17:7 reference with Man of God emblem.
|Format: Gift
Vendor: Dicksons
Publication Date: 2013
Availability: In Stock


text:
Mayor invites all to Celebration party
On behalf of the Vero Beach City Council, I am pleased to extend this invitation to all the residents of the City of Vero Beach and Indian River County to join us at the 90th Anniversary Celebration to be held on October 16, 2009, from 5:30 p.m. to 8:30 p.m. in Downtown Vero Beach.
Quite a bit has changed in Vero Beach over the past 90 years. But one thing hasn't the small-town atmosphere that has remained despite the advancement of everyday technology.
At the celebration, we will recognize some of Vero Beach pioneers and then cut the cake. Then there will be entertainment throughout the night with bands ranging in style from blue grass to golden oldies.
Again, thank you for allowing me to serve as your mayor. I look forward to seeing you at the 90th anniversary celebration.
Sabin C. Abell, Mayor
City of Vero Beach
Subscribe to TCPalm
Need Help? Call us at 1-877-710-6180.
Monday-Friday: 6am-3pm / Saturday: 6:30am-10:30am / Sunday: 7am-11am


text:
Show moreless
This property allows you to book online with a credit card. After submitting a reservation request, the owner or manager has 24 hours to accept, at which time your card will be charged and you will receive an email confirmation
Recent USVI/St. John reviews
"My wife and I have been to St. John three times (staying once in the owner's other villa) and each time it is of course fantastic. Calypso was a great home away from home with everything you need from kitchen supplies, coolers, beach stuff (and for kids!) and cards for the late night games. We brought our two kids aged 5 and 3 and the villa manager set up one room for them as we stayed next door. We also brought my wives parents and all four of the adults agreed that Calypso was the nicest villa we have stayed in so far. The hot tub is a great plus even though the weather is always perfect. The porches are great to relax outside and even in a 3BR you have so much space sometimes it is hard to find each other! The pool is awesome with great views and really what else can you ask for. The location is right next to the supermarkets and Cruz Bay for the late nights or early dinners and drinks. We would highly recommend, though it seems many agree as it is ALWAYS booked! Thanks to the owners for a wonderful time and we will be back again next year!"Guest: Eric D. Date of Stay: January 2015 Review Submitted: February 12, 2015View listing
"We have been to St. John 20 times and for the last 8 years we have stayed at Haiku. The house is well designed and well maintained. The views are nice, it is private and very well located and convenient to town. It suits us perfectly whether there are just the two of us or we have a houseful of children and grandchildren. The open plan creates a lot of living space. We have booked our next visit."Guest: Mac Date of Stay: December 2014 Review Submitted: February 5, 2015View listing
"If you love the beach, what could be more perfect then vacationing on one of St John's beautiful beaches. The front yard is literally on Gibney Beach. It proved to be the perfect get away for two and we are making plans to return next year. A second house on the property is larger and would be good for two couples or a family with children. I totally agree with the rave reviews that are already posted. The beach cottage is charming and well taken care of by the owner, who lives on the property. Located inside The Virgin Island National Park, it is a short easy drive to Cruz Bay and the other famous North shore beaches. The owner Teri and the groundskeeper Israel are very friendly and eager to help make your stay wonderful. The Gibney family are a part of St John's history and are mentioned in books about St John. I loved staying at The Gibney Beach Cottage and am no longer searching for the perfect villa for our St John vacations."Guest: Linda Date of Stay: February 2015 Review Submitted: March 9, 2015View listing
"We had a glorious family vacation week on St. John, made all the better by our stay at Villa Beija Flor. The view was amazing! We ( 4 adult couples, one with a 3 year old) were very comfortable in our own rooms with private baths... ( a small folding cot was provided and perfect for the little one). We loved relaxing and having meals on the decks, (and being able to cook them ourselves when we wanted ) and being able to leave the doors open to the breezes. The décor is beautiful and has a definite "island" feel...but we did have to do some simple "childproofing" .....just moving valuable items out of reach of little fingers...and devising a "barrier" between the upper deck and the stairs to the lower deck/pool area...neither of which were real problems. The location was great....far enough away from the noise/commotion of downtown, but not so far away as to prevent us from exploring 6 beautiful beaches! (although driving up and down the hills...especially on the left side of the road took some getting used to). Definitely need your own vehicle to get around...we rented jeeps on St. Thomas and took the car barge with no problem. We had a wonderful time!!!"Guest: Just a bunch of mothers Date of Stay: December 2014 Review Submitted: January 3, 2015View listing
Featured Destinations: The Villages, Rosemary Beach, Destin Condo Rentals, Amelia Island, Myrtle Beach, Outer Banks


text:
1962 Lincoln Continental Convertible. Runs good but needs a master... More
We are proud to offer this very original, well maintained 1962 Lincoln Continental Sedan... More
'62 Lincoln suicide door convertible, Photo documented restoration, drives magnificently! Rebuilt... More
1962 LINCOLN CONTINENTAL CONVERTIBLE  ... More
1968 Lincoln Continental Lehmann Peterson LimousineThe limousines of Lehmann Peterson are known... More
1962 Lincoln Continental Presidential Town LimousineTo be OFFERED AT AUCTION at Auctions... More
-face for 1963, lost the somewhat fussy styling it had displayed in 1961-1962, and its 1964 models were a nice... More
! Cadillac Biarritz, Chrysler, Lincoln Continental, Oldsmobile, Convertible, Mercury, Ford, Chevy Belair, etc... More
LINCOLN Continental 1962-1979 parts, also have 1948 Lincoln grille; call for price and availability... More
LINCOLN grilles 1931, 1935-1941, 1958/59; Continental 1962-64; hubcaps 1920s. 858-272-0583, CA.**45... More


text:
European goldfinches and canaries
Singing European Goldfinches. Nice and healthy birds. Asking $60 each.
I also have some canaries . Males and females.
Call or text 3169939489
finch cage bird
Jul 1 -
Canaries for sale.
Orange female with 3 babies. Babies are 12 days old. $75 without cage and $100 with cage.
White female with 2 babies. Babies are 1 week old. $85 without cage. $100 with cage.
Yellow female $40
Agate male $50
All are 2014 birds.
Call or text 3169939489
Canary finch bird cage
Jun 30 -
male canaries
2 males canaries 2 years old am/singers $50 each
no cage no ship laporte ind 219-879-9208
I live one hour from Chicago
Jun 30 -
red factor canaries and yellow American singers
Beautiful canaries contact me 331-222-1162
Jun 30 -
baby russian canary for sale $45. european goldfinches for $60 each.
Trying to sell my baby's Russian canaries. Pure blod line but not trained yet they are 2-3 months old. I have European goldfinches Gardelina from Europe for sale to ,they are Wilde but beautiful just finished molting and singing for fun. I have males and females plus i can take orders for Siberians Himalayan and other finches to. Starting from 5 to 500 birds each kind .
Jun 28 -
Arlington Heights
Beautiful yellow mosaic canaries fore sale 70 $ each.I have 7 male and 10 female.Contact 773 2061481 Wood Dale ,IL
Jun 28 -
Wood Dale
canaries for sale
Beautiful Pair of breeder canaries 100.312-647 1827
Jun 27 -
canary pair
Beautiful pair healthy they r both around a year an a half for more info 708 543 5680 open to trades
Jun 22 -
beautiful canaries all colors
I have so many beautiful canaries they are a must see beautiful colors including white,peach,orange,green timbrados,and beautiful yellow too please contact me at 331-222-1162 thanks
Jun 18 -
Canary for sale
Canary for sale call for more info 773.814.5745
Jun 18 -
Des Plaines
Canaries And hand feeded cockatiel
Beautifull Canaries for sale and 1 nice and beautifull hand feeded baby cockatiel for sale for $75.00
Jun 17 -
Goldfinch canary
I have erupean goldfinch and canary for sale
Call (773) 969-1953
This ad was posted with the eBay Classifieds mobile app.
Jun 15 -
Beautiful canary
Hi... I have canary for sale singing all day beautiful color call Omar 7735929185
This ad was posted with the eBay Classifieds mobile app.
canary cages
I have four canary cages for sale. I have two show cages and I am asking 15.00 each and two flight cages for 30.00 each. Serious inquires only. Please call after 5 P.M.
Jun 14 -
West Dundee
English Budgies, Gouldian a Finches, Zebra Finch Mutation, Canaries
Hello, I have English Budgies bonded pairs and singles $90 bonded pair or $40 for singles. Gouldian finch pair close banded 2014 proven pair $175, single males $70 each , 1-3 yrs awesome parents. White Black Cheek Zebra finch bonded pair $50 pair. Canary pairs $115 ., lipochrome white mosaic and yellow silver mosaic. Please text or call, no emails please. Serious replies only and Prices ...
Jun 11 -
I have canaries for sale. Male and females for $40 each. More info text 224-577-5535. Se habla español.
Jun 11 -
Round Lake
Russian canarie pair with banys and cage
hello I have a pair of Russian Canaries 2014 and 2015 a breeding pair already have nanys in nest I also have a pair of American singers 2013 and 2015 they come with ther cages and nest I am askin for $140 for the russians and $120 for the american pair if interested you can contact me at 773 524 7442 thank you
I have canary for sale male and female all color red yellow white green
And I have frill canary and goldfinches very good price call Omar 773 5929185
This ad was posted with the eBay Classifieds mobile app.
mosaic females canaries
I have 3 females canaries for sale they are mosaics $50 each
Jun 10 -
six young canaries ..unsexed..2015 birds...$50 each
local pick up only in area of Michigan city and la porte in 46350
phone 219 879-9208 (no cage) look like more males
Jun 10 -
Nice and beautiful birds. $50.00 each. Best offer.
May 29 -
Spanish Timbrando Canaries and Goldfinches
I have 4 Spanish timbrando canaries for sale, along with many goldfinches. Canaries are 45$ each and Goldfinches are starting from 65$ each
This ad was posted with the eBay Classifieds mobile app.
May 22 -
One 1-year-old white unknown breed hen.
One 2.5 year old cinnamon American Singer hen.
One 4 Month old brown American Singer mix male. Sings.
$30 each.
Contact by email; pickup only.
May 22 -
canaries for sale
May 21 -
We'll be sending text message alerts for your subscription to


text:
FCPA Compliance and Ethics Report-Episode 174-Matt Kelly on Dodd-Frank, Uber and Upcoming Compliance Week events
Roger Arnold Says The Worst is Behind Us in Greece
FCPA Compliance and Ethics Report-Episode 173-Adam Turteltaub on upcoming SCCE events
Is Your Financial Institution the Next Target of a Cyber-Attack?
FCPA Compliance and Ethics Report-Episode 172-Scott Killingsworth on Personal Liability of CCOs
Preparing a Company to Deal With Activist Investors
Open for Business: Who's Investing in Latin America
FCPA Compliance and Ethics Report-Episode 170-Yas Froemel and Facilitation Payments
FCPA Compliance and Ethics Report-Episode 169-the First Mailbag Issue
FCPA Compliance and Ethics Report-Episode 167-Mara Senn on the Top 10 Practices in a Cross-Border Investigation
FCPA Compliance and Ethics Report-Episode 166-Sepp Blatter Resigns
FCPA Compliance and Ethics Report-Episode 165-BHP FCPA Enforcement and Lessons Learned for the Compliance Practitioner
FCPA Compliance and Ethics Report-Episode 163-the FIFA Indictments, with Mike Brown
FCPA Compliance and Ethics Report-Episode 162-Kristine Robidoux on new Canadian whistleblower initiatives
FCPA Compliance and Ethics Report-Episode 160-Compliance Week 2015 Wrap Up with Mike Volkov and Jay Rosen
FCPA Compliance and Ethics Report-Episode 159-Alison Taylor on the intersection of CSR and the FCPA
FCPA Compliance and Ethics Report-Episode 158-Jeff Lurie on pre-acquisition M&A protocols
FCPA Compliance and Ethics Report-Episode 157-Training of Third Parties Under the FCPA
FCPA Compliance and Ethics Report-Episode 156-emergency podcast on Deflategate and the Wells Report
Episode 155-Mara Senn on FCPA Investigations and the Decision to Self-Disclose
The Bankruptcy Code offers several advantages for the creditors of financially distressed individuals and corporations, including federal court supervision of a possibly untrustworthy debtor and mitigation of the risk of...more
Hall of fame horse racing jockeys Laffit Pincay, Jr. and Chris McCarron first sued their former business managers, Vincent and Robert Andrews, in California District Court in 1989 for fraud, breach of fiduciary duty and other...more
Two recent decisions from the Fifth Circuit and Eighth Circuit could expand the fraudulent transfer exposure of unknowing third parties that provide goods, services, or funding to companies operating Ponzi...more
A just-issued Court of Chancery decision clarifies, and possibly expands, creditors' rights. In 2007, the Delaware Supreme Court ruled that a corporation's creditors may sue its board of directors for violating its fiduciary...more
In yesterday's post, we discussed when a lender's failure to comply with guidelines under the federal Home Affordable Mortgage Program (HAMP) might violate N.C. Gen. Stat. § 75-1.1 as well. We analyzed a very recent federal...more
This issue of the Credit Crunch Digest focuses on recent forex settlement agreements; rate-swapping claims in a Libor consolidated action; Bank of Tokyo's $315 million settlement with the New York Department of Financial...more
A chapter 7 trustee sued a manager of three limited liability company (LLC) debtors for breach of fiduciary duty and to hold the manager personally liable for distributions made to members, including himself....more
On July 9, 2014, in Citizens State Bank Norwood Young America v. Gordon Brown, et al., the Minnesota Supreme Court held that Minnesota's Uniform Fraudulent Transfer Act ("MUFTA") may be applied to transfers of assets made as...more
Companies that have valuable assets but also face significant liabilities will sometimes engage in restructurings to isolate, or "ring-fence," the good assets from the liabilities. Often the companies are able to accomplish...more
In her first published decision, rendered in Mexico Construction and Paving v. Thompson (In re Thompson), Case No. 11-32924, Adv. Pro. No. 12-03065 (Bankr. D. Conn May 22, 2014), Judge Julie A. Manning held on the basis of...more
In 2008, a few months before the $65 billion Madoff Ponzi scheme fell apart, the $3.65 billion Petters Ponzi scheme made headlines. Tom Petters told investors that they were financing the purchase and sale of consumer...more
The Commission brought an action against a securities law recidivist and his entities who had raised about $22 million in a fraudulent investment scheme. When the action was filed a temporary freeze order was obtained. Later...more
In an April 27, 2014 decision in the Madoff cases, Judge Jed S. Rakoff ruled that the standard of good faith should be considered differently in a Securities Investor Protection Act (SIPA) liquidation. To defeat a good faith...more
In that case, Walnut Creek Mining Company ("Walnut Creek"), the debtor Optim Energy's largest unsecured creditor, sought standing to pursue recharacterization, equitable subordination, and fiduciary duty claims on behalf of...more
When a corporation suffers significant losses, or ultimately fails, frustrated shareholders, creditors, or others often try to sue the corporation and/or its officers and directors for losses caused by mismanagement of the...more
In a recent case — In re Optim Energy, LLC — the Delaware Bankruptcy Court denied an individual creditor's request to pursue the subordination or recharacterization of the claims of secured lenders who were also the debtors'...more
Debts based on fraud are not dischargeable in bankruptcy, but to achieve that result the aggrieved creditor must ordinarily commence a non-dischargeability action and prove the fraud. However, when an action for fraud is...more
The Employee Retirement Income Security Act of 1974, as amended ("ERISA"), requires trustees of multiemployer pension and benefit funds to collect contributions required to be made by contributing employers under their...more
Kurtz v. Liberty Mutual Insurance Co., et al., Case No. 2:11-cv-7010 (C.D.Cal. April 14, 2014), was an insurance coverage dispute arising out of the downfall of Los Angeles businessman Ezri Namvar who has also been referred...more
Last Tuesday, Puerto Rico sold its much ballyhooed $3.5 billion in non-investment grade general obligation bonds. Two days later, two legislators in Puerto Rico's Senate filed a bill which, if enacted, would permit...more
In the Second U.S. Circuit, the so-called Wagoner rule deprives a trustee of standing to sue third parties, such as lawyers and investment bankers, if the bankrupt corporation participated with them in defrauding creditors. A...more
As of August 2013, since the fallout from the recent financial crisis, the FDIC as receiver for failed banks has brought suit against former directors and officers of 76 failed institutions. These lawsuits are based on...more
Sept. 12 (Bloomberg) -- The possibility that the most significant decisions affecting Detroit will not be made in bankruptcy court elevates the motor city to the "Case of the Week" status on the bankruptcy video with...more
The recent New York case of Lichtenstein v. Willkie Farr addresses a borrower's conflict caused, in part, by a loan covenant. The covenant invoked personal liability of the members in the event the entity files a voluntary...more
In Sun Capital Partners III, L.P. et al. v. New England Teamsters & Trucking Industry Pension Fund, No. 12-2312, 2013 WL 3814985 (1st Cir. July 24, 2013), the First Circuit held that a private equity fund could be liable for...more
Find a Finance & Banking Author »
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up to create your digest using LinkedIn*
Back to Top
Copyright ©


text:
Don't let the cover or the photo on the back fool you, these guys wouldn't know emo rock if they tripped over it. Instead, Toronto's Turn Off the Stars shine with an extremely refined, polished and pristine collection of tunes that will strike a nerve with any Coldplay, U2 or Keane fan. "I Wasn't Ready" has a great mix of music and lyrics, with lead singer Michael Walker hitting those high notes time and time again, while the other band members wield terribly sweet music behind him. At the same time, Turn Off the Stars excels with moodier pieces, such as "Please", "Getaway", and the larger, lush "Falling Into You", that instantly makes one think of Chris Martin and Company. So does the earnest, mid-tempo and melancholic, "Hours & Days", which is a bit lighter on the guitars. The fifth song, often a dropping off point for most albums, is just as consistent as the band maintains this high quality groove during "30 Days". Nothing here is filler or padding, particularly going by a tender, terribly melodic effort like "Nowhere Skies", that again would give one a rush of blood to the head. While the comparisons to Coldplay might be endless, these songs are from a band which sounds like it's never gone through the motions. "Lately" is one of the second half highlights on an album with many such highlights.
- Multiple songs MySpace
- Multiple videos YouTube
Colette Carr "Static" (video) (Premiere) // Music
House of Blondes "First of July" (audio) (premiere) // Music
Digisaurus 'No More Room For Love' (EP stream) // Music
Fave Five: Alpine
// Sound Affects
"Australian sextet Alpine's newest album is a fantastic expansion of their joyous pop sound, but two members give us five records apiece that helped define their unique musical identities.READ the article


text:
Original recipe yields 8 servings
Amount per serving ({{servings}} total)
Based on a 2,000 calorie diet
Ready In
This was the perfect side for my Labor Day BBQ. I wanted something a little different and this was it. The lime dressing made it nice and zesty and I loved the idea of adding chiles and green o...
I'm making it the 2nd time. My family really enjoyed it -- different, yet all the flavors come together nicely!


text:
Brad Pitt debuts short new haircut without hat, looks years younger
Brad Pitt is 49 years young! With Angelina Jolie and their six kids a world away in Australia, the actor got to work on the London set of his new film "Fury" on Sept. 14 -- and gave fans the best glimpse yet of his drastic new haircut. After growing out his world-famous blond locks for years -- his hair was past his shoulders earlier this summer! -- Pitt first debuted the new look last week, although much of the new 'do was hidden beneath a baseball cap.
This time, however, the "World War Z" hunk was cap-free and looked years younger with the handsome new cut, which appears to be shaved on the sides and the back, with the top left a bit longer in a wavy, GQ-sharp side part.
PHOTOS: Brad's facial hair evolution
And it appears that Pitt, whose latest look is likely for the new flick, made a good move: A recent Us Weekly poll had 85 percent of respondents favoring Pitt with short versus long hair.
PHOTOS: Brad's many movie looks over the years
No word yet on when Pitt might be able to reunite with love Jolie, 38, and the gang: She's at work herself on her next directorial effort "Unbroken Down Under," and has been spotted taking in the sights with kids Maddox, Pax, Zahara, Shiloh and twins Vivienne and Knox. "Yeah, she's got her hands full," Pitt joked to Access Hollywood. "I'm actually jealous."
Keep clicking for more photos of Brad ...
Get out the vote
Sign up for celebrity breaking news!Please enter a valid email addressBy signing up I accept the Terms of Use and Privacy PolicyThanks for subscribing!Show CommentsNextWhen using Facebook Connect your image and name may display on Wonderwall. All Privacy Settings are controlled by Facebook
- button.LOVE
- button.MEH
- button.HOT
- button.WOW
Like us on Facebook?
UP NEXTEye Candy!
From Elle
From Crowd Ignite


text: MANSTAGRAM New on TMR: pants in the park. Cc @charbarbar Follow Man Repeller August 16, 2012 FACEBOOK TWITTER PINTEREST EMAIL IT READ NEXT Fashion: In Defense of Slow Fashion Humor: You're Probably Type A-Minus Style: Man Repeller to Getter with Help from a Fashion Editor Humor: July Horoscopes Are Here! Style: How to Wear a Flower in Your Hair Without Looking Like an A-Hole Humor: Red, White and Blues Shopping: Americana Shopping: Fact: I Use Instagram to Pack for Weekends Away REPLIES SHOW MORE COMMENTS


text:
Department of Housing and Urban Development
Nearly 300 volunteers have until 2 a.m. to find and survey every homeless person they can find on the streets of Washington, D.C. It's part of Department of Housing and Urban Development's annual point-in-time count of the homeless. Continue reading
WASHINGTON — The Senate easily confirmed San Antonio Mayor Julian Castro on Wednesday to head the Department of Housing and Urban Development, boosting the national profile of a Democrat with a compelling biography who's considered a vice presidential contender in 2016. Continue reading
President Barack Obama is preparing to boost the profile of an up-and-coming young Hispanic Democrat by nominating San Antonio Mayor Julian Castro to become the nation's housing secretary. Obama's current housing chief gets a new title: budget director. Obama was expected to announce his latest Cabinet shuffle at the White House on Friday afternoon, a White House official said, shortly after he returns from an overnight trip to his Chicago hometown to raise money for Democratic Senate candidates. Continue reading
More than 75 percent of public housing in New Orleans is unfit for human habitation after Hurricane Katrina. Rebuilding plans for these homes are underway but will take time, even though residents are ready now to return home. Continue reading


text:
Americans detained in North Korea released
Published: Sep 01 2014 11:36:46 AM EDT Updated On: Nov 08 2014 01:31:32 PM EST
Kenneth Bae and Matthew Todd Miller, two Americans who were being held in North Korea, were released Saturday. Learn more about the three Americans most recently detained in North Korea.
The views expressed are not those of this company or its affiliated companies. Please note by clicking on "Post" you acknowledge that you have read the TERMS OF USE and the comment you are posting is in compliance with such terms. Your comments may be used on air. Be polite. Inappropriate posts may be removed by the moderator. Desktop and mobile versions of this site use independent comment threads.


text:
Inactive Ingredients: Cod Liver Oil (Contains Vitamin A & Vitamin D), Fragrance, Light Mineral Oil, Microcrystalline Wax, Paiffin.
Added to My List as a guest*.
*Your guest list will be temporarily saved until you end this browser session.
A + D Original Ointment Diaper Rash & Skin Protectant -- 1 lb
Oops! Something went wrong and we were unable to process your request. Please try again.
Diaper rash. If babies could talk, they'd have plenty to say about this most irritating of ailments. But A+D Skin Protectant Ointment will leave them speechless. It protects skin from chafing and minor irritation, and seals out wetness, the enemy chief enemy of baby bottoms. An application of A+D after a diaper change will soothe babies' skin and tempers. This ointment can also be used on chafed, chapped, or cracked skin and lips.
Helps treat and prevent diaper rash. Temporarily protects minor cuts, scrapes, and burns. temporarily protects and helps relieve chapped, chafed or cracked skin and lips. Helps protect from the drying effects of wind and cold weather.
For Skin Protectant Use: apply as needed.
For Diaper Rash Use: change wet and soiled diapers promptly, cleanse the diaper area, and allow to dry. Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.


text:
At A.D.O.P.T. Pet Rescue, in Columbus Ohio, we work tirelessly to ensure that no dog or cat is forced to suffer cruelly by wandering the streets, with no home to go to and no one to provide warmth and love. The members of A.D.O.P.T. are dedicated to this effort because each of us know that…
At A.D.O.P.T. Pet Rescue, 100% of your donation goes directly towards furthering our goals of finding permanent happy homes for our animals and caring for them until we do.
Foster homes desperately needed for dogs, cats, puppies, and kittens!
We supply food, crates, litter, and all medical expenses. You provide a safe and loving home until the animal gets adopted.
ADOPT will be at House Wine in Worthington from 6-9pm this Tuesday for a night of wine and fundraising! Stop by anytime between 6 and 9 and mention that you are there for ADOPT and a portion of your sale will go back to ADOPT – it's that simple! It's a great cause and sure […]View Details
Just a reminder that you can support ADOPT when you make purchases on Amazon.com by shopping on smile.amazon.com! Once you set up your AmazonSmile account to support ADOPT, a percentage of your purchases will automatically go to ADOPT whenever you do your shopping through smile.amazon.com! Click the button below to get your account set up and […]View Details


text:
Bad Mouse Digital Art is an independent video game developer located on Chile South America. We currently develop indie games and remakes of classics games for the PC.
You are not logged in, your comment will be anonymous unless you join the community today (totally free - or sign in with your social account on the right) which we encourage all contributors to do.
2000 characters limit; HTML formatting and smileys are not supported - text only


text:
Is your resume in need of a little disruption?
Startups are all about
making things work better.
Our resume writing service is all about doing that for your CV.
StartUpHire is the place to find Mobile-Developer jobs in and near . Review the list below of Mobile-Developer jobs. These Mobile-Developer jobs represent some of the most rewarding careers available. You can refine your job search for Mobile-Developer jobs in by adding a job title, company name, or keyword to the search box above … or click the "Advanced Search" link for more options. Don't see the employment opportunity you're looking for? Check back soon for more Mobile-Developer jobs in , or sign up for an email alert (link in upper left) to receive periodic updates on new Mobile-Developer jobs in , .
Requisition Number:692 Job Title:Front-End Developer Area of Interest:Marketing Position Type:Full Time - Permanent Shift: Location:Remote Employees-Home Based City:Nationwide-Remote State / Province:Nationwide-Remote Requirements: See Job Description Below Job5/29/2015 Jacksonville, FL Save This Job
TECHNOLOGY - Chicago HelloWorld Mobile Applications developers build, support and maintain rich, interactive and high performance native mobile applications. At least 3 years of professional experience in either native iOS or Android development is required and5/19/2015 Chicago, IL Save This Job
Redwood City, CA Company Description Are you an ambitious, competitive go-getter with a positive attitude? If so, we want to talk to you! Headquartered in Silicon Valley, Satmetrix develops software used by businesses of all sizes to measure and manage the Customer Experience5/12/2015 Redwood City, CA Save This Job
Description The Mobile Application Developer will be responsible for the App development functions of technologically advanced medical devices. This includes bringing a product from idea/concept through design, write source code, development testing, design verification and5/3/2015 Audubon, PA Save This Job
Job Description As part of our continued growth in Milwaukee, WI, Provade is interviewing candidates for a Software Developer. This individual will be a key player in the future strategy of Provade and its leadership as the premier Vendor Management System (VMS) solution4/29/2015 San Mateo, CA Save This Job
Menlo Park AnchorFree?s mission is to provide secure and private access to the world?s information for every person on the planet. AnchorFree?s Hotspot Shield app is the world?s most popular freedom and privacy platform. Hotspot Shield is the starting point, for mobile and Web7/1/2015 Menlo Park, CA Save This Job
More information about this job: About Everyday Health, Inc.: Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health and wellness solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health6/17/2015 Manhattan, NY Save This Job
We are not just a mobile payment application. We are not just a start-up company. We are entrepreneurs eager to change an industry. We are intensely curious about hospitality, company culture, mobile technologies and changing the way consumers pay their restaurant and bar tabs.6/17/2015 Austin, TX Save This Job
MomentFeed is a digital marketing platform that connects brands and consumers at the local level. The platform empowers major brands including Pizza Hut, AT&T, and The Home Depot to capture local audiences, engage with consumers in authentic and locally relevant ways, and measure5/27/2015 Santa Monica, CA Save This Job
Description We are looking for a talented front-end developer with mobile experience to join an exciting new team. This individual will be part of the core development team that will build front-end interfaces (in a variety of technologies) that will harness the capabilities of3/25/2015 Cincinnati, OH Save This Job
Clinicient is hiring a Sr .NET developer with experience developing in .NET, C#, SQL, HTML, CSS and AngularJS. ESSENTIAL DUTIES AND RESPONSIBILITIES Software design and development using advanced object-oriented and functional programming concepts. Create automated unit and5/20/2015 Portland, OR Save This Job
Mobile Analytics Technical Lead Background Carrier iQ enables the communications industry to deliver on their promise of talking and surfing from anywhere by delivering Mobile Intelligence to our customers ? mobile network operators, device manufacturers and market research5/12/2015 Westborough, MA Save This Job
Job Description As a Senior Android Software Developer you will join a dynamic team responsible for the development of user-facing mobile video conferencing software running on multiple mobile platforms and play a pivotal role in shaping its future generations. We are looking6/3/2015 Hackensack, NJ Save This Job
About Ticketfly Ticketfly is making life better for the live events community with innovative technology that improves the fan experience from discovery to attendance and beyond. We are challenging the status quo by centering the experience around the fan and building a powerful5/27/2015 San Francisco, CA Save This Job
VerbalizeIt, a TechStars alumnus, delivers instant access to a global community of human translators over the phone, through Skype and via the web. We are disrupting the translation landscape by providing superior quality translation than what is delivered by machine-based5/26/2015 New York City, NY Save This Job
Job Description: Audience seeks a highly accomplished and self-motivated Algorithm Developer, who will be responsible for the research, development and deployment of algorithms for context inference applications through integrating information across voice, motion, biometric, and5/18/2015 Mountain View, CA Save This Job
Job Description: Audience seeks a highly accomplished and self-motivated Algorithm Developer, who will be responsible for the research, development and deployment of algorithms for navigation and context inference applications through integrating information across voice, motion,5/18/2015 Mountain View, CA Save This Job
We're looking for a developer who wants to join a team of passionate, entrepreneurial self-starters here at RunKeeper. Your skillset will expand with each passing day at RunKeeper, as you work with our Marketing and Brand teams to maximize our user acquisition, Elite offering5/17/2015 Boston, MA Save This Job
Sr. Software Developer sought by Smarter Agent in Camden, NJ to develop enterprise-class client/server applications to power our mobile & internet offerings. Requirements: MS (or equiv) +2 yrs exp. Developing applications on mobile platform using Java/J2ME, CLDC, MIDP &5/11/2015 Camden, NJ Save This Job
At eHarmony, we've never shied away from big challenges. We came together in 2000 believing that with a mix of psychology and some cutting edge technology, we could create relationships that were happier, more fulfilling and enduring.6/7/2015 Santa Monica, CA Save This Job


text:
Deviant Art
SR: Gay Marriage in IllinoisSo the House here in Illinois just passed (61-54) Senate Bill 10 which legalizes 'gay marriage.' The flood of Facebook messages: "Finally" and "I'm so happy" and "#equality." Politicians coming out as gay, companies contorting their image so as to appear inclusive, and anyone who would dare oppose something such as gay marriage are hit with salvo after salvo of "equal protection under the law" and "human/civil rights."More Like This
In all the breakdown of certain values, such as "marriage is not a natural institution" and "marriage is not sacred" among other things lawmakers and individuals alike have decided that the former view of marriage is limiting and prejudiced. Regardless of what you believe I imagine any thoughtful reflection on the whole situation reveals a rather odd phenomenon.
Whereas it seems that everything that was once held as common-sense and true is now irrational and false, the invocation of a universal truth has taken form, not of God or of nature, but of the Constitution.
How A Christian Feels About HomosexualsThere is a very big assumption that has been going around for the past few years, and that is, "If you don't support gay/lesbian couples, you are backwards-thinking, unreasonable and cruel." (Maybe some of you will fight against this shallow thinking in the comments by not only understanding homosexuals, but also understanding Christians?) I hope that this thinking will change overtime, because if homosexuals have a right to voice their beliefs, don't heterosexuals also have a right?More Like This
I don't support the choice homosexuals have made for their lives, but that doesn't mean I hate them. In fact, I actually have a few friends who are bisexual/homosexual.
Now, I do know that there are a few churches who have done very nasty things in protest of gay marriage, but there have also been a few groups of homosexuals who have done equally unreasonable things to "fight back" at these churches. But is it fair to judge the majority of all churches and all C
The Convenience of EqualityMore Like This
The topic of marriage is no stranger to Americans in recent weeks. The Supreme Court, in a 5-4 split decision, ruled that DOMA (the Defense of Marriage Act) was unconstitutional because it failed to offer homosexuals "equal protection under the law" and that the purpose of DOMA is to "humiliate" and "injure" homosexuals who seek marriage.
No doubt a number of individuals celebrated the ruling, happy, perhaps, to see the archaic edifice of 'traditional' marriage burn and establish a sleek and modern "marriage" in its place. Many rejoiced at the new building, but many of us looked on and asked to see the building plans.
Arguments for "marriage equality" are many times the product of convenient reasoning. The typical strain of equality reasoning usually goes along the lines of this: We can't expect everyone to go by one definition of marriage, nor should the government force one view over the other. Moreover, th
You Are WorthyYou died for meMore Like This
on that dreadful day
On that day You showed me Grace
That someone like You
would be pierced through
for my sin, my filth and my disgrace
So I thank You God
with not only words
but with love and it falls short
of all You've done for me
how You set me free
You gave me love
and gave me hope
For You are worthy
Oh so worthy
For You are worthy
Oh so worthy
You are my love
my truth
my only hope
My Journey to FaithMy own journey to faith has been a long complex one.More Like This
Like most African Americans of the 30's, my parents were raised in the church, but neither
of them were really Christians. Furthermore my dad had a bitter experience in church when he
was young that forever soured him to religion and he had absolutely no interest in it.
Mom believed in God and enjoyed watching Robert Schuller's on TV, but her belief in God was mixed
with a hodgepodge of other things, including reincarnation. She was also a firm believer in 'to each his own.'
She thought that all paths led to God and that as long as one led a good life that was enough.
Despite this, God had His hand on me, because from the time I was little I instinctively sought Him.
Very early on I had a deep curiosity and hunger for spiritual things. I loved Bible stories and was
very curious about God. On the few occasions my mom or some other relative took me to visit a church
or Sunday school, I always felt a strange yearning. I wanted something
Hell's Dominion A Near Death ExperienceWhat is up every one?More Like This
I figured I would post another religious video for all the people of deviantart to enjoy. This video is about a guy who had a near death experience and saw Jesus and went to hell and came back to tell his tale.
Thanks for reading and have a nice day.
|Sta.sh Submit


text:
Student Opts Out of Dorm and Builds Tiny House Instead, Graduates Debt-Free
The most expensive part about college isn't always the textbooks or the classes, it's actually the dorms and the meal plans. Almost 69% of seniors from public and nonprofit colleges in 2013 had student loan debt, owing an average amount of $28,400. You know, the price of a brand new car. But a University of Texas student decided he could avoid owing a ton of cash by opting out of college housing without having to live at home. Using concepts and skills he learned in his design classes, 25-year-old Joel Weber built a 145-square-foot space instead of taking out massive loans to pay for college housing. The property cost around $20,000 total, and says he now plans to graduate debt-free. The only thing he's really missing is a compact beer pong table that can be folded into the wall or something, am I right? To read more about Weber's interesting choice of college housing, check it out here.


text:
Did you know the Valentine RHC has millions of uncatalogued photos of RVA that need to be logged? Volunteer!
Landmark Theater
Live Music music venue The Mosque Broadway The Richmond Forum Concerts Lectures Ornate Moorish Revival Monroe Park The Fan Entertainment
6 North Laurel Street
Richmond, VA 23220
804-646-0546Website Twitter Facebook
The Landmark is where traveling Broadway shows, giant name comedians and internationally renowned speakers come to remind us that we're better than Raleigh, NC.


text:
back by popular demand:
New Patient Exam with Adjustment and More
Kenmore Chiropractic
If the weight of your hectic schedule is starting to leave you feeling out of alignment, it's time to straighten things up with a quick trip to Kenmore Chiropractic:
• $34 ($100 value) for a new patient examination package
• Includes spinal adjustment, cold laser therapy, and Graston Technique treatment
• Appointments are available Monday through Saturday each week
Why We Love It
Your consultation can help determine which specific problem areas could benefit from treatment, and your spinal adjustment can provide welcome relief from tensions, aches, and pains. Cold laser therapy is approved by the FDA to provide relief from joint and muscle pain, and the Graston Technique can help diagnose and treat a variety of disorders of the skeletal muscles and related connective tissue.
Kenmore Chiropractic's Website
PAID VALUE EXPIRES ON June 30, 2020
PROMOTIONAL VALUE EXPIRES ON November 24, 2013
our good deal guarantee covers…quick & easy refunds X
quick & easy refunds
Buy this Deal with confidence, because it's covered by the LivingSocial Good Deal Guarantee up to the Voucher Expiration Date.
See more here


text:
Add these to your next summer party or lazy afternoon on the deck—you can scoop without stress, thanks to Hungry Girl Lisa Lillien's...
10 Smoothies We Can't Stop Sipping
2 cups fresh baby spinach
½ cup freshly grated Parmesan cheese
2 Tbsp pistachios
½ tsp salt
1 peeled garlic clove, halved or smashed
⅔ cup extra-virgin olive oil
Rinse and dry spinach in a salad spinner. Add all ingredients in a food processor or blender and pulse until smooth.
Trick Out Your Baked Potato